This protocol covers the clinical management of epilepsy with myoclonic absences in adults — specifically patients aged 16 years and older — where antiepileptic treatment follows evidence-based guidelines for the adult population.
Patient is aged 16 years or older and presents with epilepsy with myoclonic absences. Adult-specific treatment considerations apply to this population.
Management in this age group may progress to combination antiepileptic therapy when initial treatment proves insufficient. The complete regimen — including which agents are indicated, in what sequence, and how to escalate — is detailed in the full protocol.
Adults
Monotherapy with all indicated AEDs should be attempted before initiating combination therapy.
View source ↗